It is well established that the HFD can induce hepatic steatosis in rodents through an increase in the expression of transcription factors like SREBP1c, a major activator of lipogenic genes and peroxisome proliferator-activated receptor alpha (PPARα), and the enzymes FAS and ACC in mouse livers (35). This evidence concerns the gene SREBF1 and fatty liver disease.